{"id":6017,"date":"2018-10-10T13:44:17","date_gmt":"2018-10-10T13:44:17","guid":{"rendered":"https:\/\/oncopeptides.com\/about\/corporate-governance\/kommitteer\/valberedning-2019\/"},"modified":"2018-10-10T13:44:17","modified_gmt":"2018-10-10T13:44:17","slug":"valberedning-2019","status":"publish","type":"about-us","link":"https:\/\/oncopeptides.com\/sv\/om-oss\/corporate-governance\/kommitteer\/valberedning-2019\/","title":{"rendered":"Valberedning 2019"},"content":{"rendered":"<p><strong>Enligt de principer f\u00f6r tills\u00e4ttande av valberedning i Oncopeptides AB (publ) som antogs vid \u00e5rsst\u00e4mman den 17 maj 2018 ska valberedningen inf\u00f6r \u00e5rsst\u00e4mman 2019 best\u00e5 av ledam\u00f6ter utsedda av de tre st\u00f6rsta aktie\u00e4garna i fr\u00e5ga om r\u00f6standel per den 28 september, tillsammans med styrelsens ordf\u00f6rande.<\/strong><\/p>\n<p>Valberedningens sammans\u00e4ttning har nu fastst\u00e4llts och Oncopeptides meddelade idag att valberedningen inf\u00f6r \u00e5rsst\u00e4mman 2019 best\u00e5r av f\u00f6ljande personer som tillsammans representerar cirka 55 procent av antalet aktier och r\u00f6ster i bolaget baserat p\u00e5 den senast k\u00e4nda aktie\u00e4garinformationen vid slutet av september.<\/p>\n<ul>\n<li>Staffan Lindstrand, utsedd av HealthCap VI L.P.<\/li>\n<li>David Sonnek, utsedd av Stiftelsen Industrifonden<\/li>\n<li>Max Mitteregger, utsedd av GLADIATOR<\/li>\n<li>Per Wold-Olsen, styrelsens ordf\u00f6rande<\/li>\n<\/ul>\n<p>Valberedningens f\u00f6rslag kommer att presenteras i kallelsen till \u00e5rsst\u00e4mman 2019 och p\u00e5 Oncopeptides webbplats, www.oncopeptides.com.<\/p>\n","protected":false},"featured_media":0,"parent":5990,"template":"","meta":{"_acf_changed":false},"protected-content":[],"class_list":["post-6017","about-us","type-about-us","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/oncopeptides.com\/sv\/wp-json\/wp\/v2\/about-us\/6017","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/oncopeptides.com\/sv\/wp-json\/wp\/v2\/about-us"}],"about":[{"href":"https:\/\/oncopeptides.com\/sv\/wp-json\/wp\/v2\/types\/about-us"}],"version-history":[{"count":0,"href":"https:\/\/oncopeptides.com\/sv\/wp-json\/wp\/v2\/about-us\/6017\/revisions"}],"up":[{"embeddable":true,"href":"https:\/\/oncopeptides.com\/sv\/wp-json\/wp\/v2\/about-us\/5990"}],"wp:attachment":[{"href":"https:\/\/oncopeptides.com\/sv\/wp-json\/wp\/v2\/media?parent=6017"}],"wp:term":[{"taxonomy":"protected-content","embeddable":true,"href":"https:\/\/oncopeptides.com\/sv\/wp-json\/wp\/v2\/protected-content?post=6017"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}